126 related articles for article (PubMed ID: 3754971)
1. Removal of 239Pu from mice with 3,4,3 LICAM(C) or N,N',N'',N'''-tetra-(2,3-dihydroxybenzoyl)-spermine.
Szot Z; Rochalska M; Wojewódzka M; Chimiak A; Przychodzen W
Radiat Environ Biophys; 1986; 25(1):31-5. PubMed ID: 3754971
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and toxicity of N,N',N",N"'-tetra(2,3,4-trihydroxybenzoyl)-spermine for decorporation of 239Pu from mice.
Szot Z; Rochalska M; Chomiczewski K; Chimiak A; Przychodzeń W
Int J Radiat Biol; 1989 Jan; 55(1):141-9. PubMed ID: 2562970
[TBL] [Abstract][Full Text] [Related]
3. The effect of pure LICAM(C) on the retention of plutonium-238 in mice and rats.
Volf V; Taylor DM; Brandau W; Schlenker P
Int J Radiat Biol Relat Stud Phys Chem Med; 1986 Aug; 50(2):205-11. PubMed ID: 3488281
[TBL] [Abstract][Full Text] [Related]
4. Chelation therapy of incorporated plutonium-238 and americium-241: comparison of LICAM(C), DTPA and DFOA in rats, hamsters and mice.
Volf V
Int J Radiat Biol Relat Stud Phys Chem Med; 1986 Mar; 49(3):449-62. PubMed ID: 3485592
[TBL] [Abstract][Full Text] [Related]
5. Removal of Pu and am from beagles and mice by 3,4,3-LICAM(C) or 3,4,3-LICAM(S).
Lloyd RD; Bruenger FW; Mays CW; Atherton DR; Jones CW; Taylor GN; Stevens W; Durbin PW; Jeung N; Jones ES
Radiat Res; 1984 Jul; 99(1):106-28. PubMed ID: 6547537
[TBL] [Abstract][Full Text] [Related]
6. Chelation of 238Pu(IV) in vivo by 3,4,3-LICAM(C): effects of ligand methylation and pH.
Durbin PW; White DL; Jeung NL; Weitl FL; Uhlir LC; Jones ES; Bruenger FW; Raymond KN
Health Phys; 1989 Jun; 56(6):839-55. PubMed ID: 2722507
[TBL] [Abstract][Full Text] [Related]
7. Efficacies of LICAM(C) and DTPA for the decorporation of inhaled transportable forms of plutonium and americium from the rat.
Stradling GN; Stather JW; Gray SA; Moody JC; Ellender M; Hodgson A
Hum Toxicol; 1986 Mar; 5(2):77-84. PubMed ID: 3514430
[TBL] [Abstract][Full Text] [Related]
8. Octadentate catecholamide ligands for Pu(IV) based on linear or preorganized molecular backbones.
Durbin PW; Kullgren B; Jeung N; Xu J; Rodgers SJ; Raymond KN
Hum Exp Toxicol; 1996 Apr; 15(4):352-60. PubMed ID: 8845226
[TBL] [Abstract][Full Text] [Related]
9. Specific sequestering agents for the actinides: 10. Enhancement of 238Pu elimination from mice by poly(catechoylamide) ligands.
Durbin PW; Jeung N; Jones ES; Weitl FL; Raymond KN
Radiat Res; 1984 Jul; 99(1):85-105. PubMed ID: 6547538
[TBL] [Abstract][Full Text] [Related]
10. Biological behaviour of Pu administered to animals as Pu-standard LICAM(C) complex: therapeutical attempts to decrease Pu kidney burden.
Gerasimo P; Duserre C; Metivier H
Hum Toxicol; 1986 Sep; 5(5):309-18. PubMed ID: 3770768
[TBL] [Abstract][Full Text] [Related]
11. Specific sequestering agents for the actinides. 21. Synthesis and initial biological testing of octadentate mixed catecholate-hydroxypyridinonate ligands.
Uhlir LC; Durbin PW; Jeung N; Raymond KN
J Med Chem; 1993 Feb; 36(4):504-9. PubMed ID: 8386249
[TBL] [Abstract][Full Text] [Related]
12. The efficacies of pure LICAM(C) and DTPA for enhancing the elimination of plutonium-238 and americium-241 from rats after their inhalation as nitrate.
Stradling GN; Stather JW; Gray SA; Moody JC; Ellender M; Hodgson A
Exp Pathol; 1989; 37(1-4):83-8. PubMed ID: 2637176
[TBL] [Abstract][Full Text] [Related]
13. The binding of plutonium to transferrin in the presence of tri-n-butyl phosphate or nitrate and its release by diethylenetriaminepenta-acetate and the tetrameric catechoylamide ligand LICAMC(C).
Duffield JR; Taylor DM; Proctor SA
Int J Nucl Med Biol; 1986; 12(6):483-7. PubMed ID: 3754852
[TBL] [Abstract][Full Text] [Related]
14. Long-term 238Pu and 239Pu retention and organ distribution in mice at low doses.
Andreozzi U; Clemente GF; Ingrao G; Santori G
Health Phys; 1983; 44 Suppl 1():505-11. PubMed ID: 6408027
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of plutonium introduced as Tri-N-Butylphosphate complex in the rat and removal attempts by DTPA.
Metivier H; Masse R; Lafuma J
Health Phys; 1983 Jun; 44(6):623-34. PubMed ID: 6853185
[TBL] [Abstract][Full Text] [Related]
16. Targeting of diethylene triamine pentaacetic acid encapsulated in liposomes to rat liver: an effective strategy to prevent bone deposition and increase urine elimination of plutonium in rats.
Phan G; Ramounet-Le Gall B; Manceau J; Fanet M; Benech H; Fritsch P; Fattal E; Deverre JR
Int J Radiat Biol; 2004 Jun; 80(6):413-22. PubMed ID: 15362694
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and initial evaluation for in vivo chelation of Pu(IV) of a mixed octadentate spermine-based ligand containing 4-carbamoyl-3-hydroxy-1-methyl-2(1H)-pyridinone and 6-carbamoyl-1-hydroxy-2(1H)-pyridinone.
Xu J; Durbin PW; Kullgren B; Ebbe SN; Uhlir LC; Raymond KN
J Med Chem; 2002 Aug; 45(18):3963-71. PubMed ID: 12190318
[TBL] [Abstract][Full Text] [Related]
18. The distribution and retention of plutonium, americium and uranium in CBA/H mice.
Ellender M; Haines JW; Harrison JD
Hum Exp Toxicol; 1995 Jan; 14(1):38-48. PubMed ID: 7748615
[TBL] [Abstract][Full Text] [Related]
19. Competitive binding of Pu and Am with bone mineral and novel chelating agents.
Guilmette RA; Hakimi R; Durbin PW; Xu J; Raymond KN
Radiat Prot Dosimetry; 2003; 105(1-4):527-34. PubMed ID: 14527022
[TBL] [Abstract][Full Text] [Related]
20. Decorporation of Pu/Am Actinides by Chelation Therapy: New Arguments in Favor of an Intracellular Component of DTPA Action.
Grémy O; Laurent D; Coudert S; Griffiths NM; Miccoli L
Radiat Res; 2016 Jun; 185(6):568-79. PubMed ID: 27195610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
